Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 14.03
(1.08%)
CNY 14.03
(1.08%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.29 Billion CNY | -28.69% |
| 2022 | 6.01 Billion CNY | 37.74% |
| 2021 | 4.36 Billion CNY | 16.33% |
| 2020 | 3.75 Billion CNY | 11.35% |
| 2019 | 3.37 Billion CNY | -6.56% |
| 2018 | 3.6 Billion CNY | 15.17% |
| 2017 | 3.13 Billion CNY | 79.44% |
| 2016 | 1.74 Billion CNY | 168.55% |
| 2015 | 650.4 Million CNY | 396.84% |
| 2014 | 130.9 Million CNY | 336.36% |
| 2013 | 30 Million CNY | 3233.33% |
| 2012 | 900 Thousand CNY | 1404.29% |
| 2011 | 59.82 Thousand CNY | -99.6% |
| 2010 | 15 Million CNY | -51.61% |
| 2009 | 31 Million CNY | -25.03% |
| 2008 | 41.35 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 4.17 Billion CNY | -5.85% |
| 2024 Q3 | 2.82 Billion CNY | -26.69% |
| 2024 Q1 | 4.43 Billion CNY | 3.27% |
| 2023 FY | 4.29 Billion CNY | -28.69% |
| 2023 Q4 | 4.29 Billion CNY | -3.32% |
| 2023 Q1 | 6.04 Billion CNY | 0.37% |
| 2023 Q3 | 4.43 Billion CNY | -15.05% |
| 2023 Q2 | 5.22 Billion CNY | -13.49% |
| 2022 Q3 | 5.07 Billion CNY | -9.18% |
| 2022 Q1 | 4.92 Billion CNY | 12.75% |
| 2022 FY | 6.01 Billion CNY | 37.74% |
| 2022 Q4 | 6.01 Billion CNY | 18.53% |
| 2022 Q2 | 5.59 Billion CNY | 13.48% |
| 2021 Q3 | 4.66 Billion CNY | 5.35% |
| 2021 Q1 | 4.15 Billion CNY | 10.62% |
| 2021 FY | 4.36 Billion CNY | 16.33% |
| 2021 Q4 | 4.36 Billion CNY | -6.4% |
| 2021 Q2 | 4.43 Billion CNY | 6.64% |
| 2020 Q2 | 4.49 Billion CNY | 19.22% |
| 2020 Q1 | 3.76 Billion CNY | 11.67% |
| 2020 FY | 3.75 Billion CNY | 11.35% |
| 2020 Q3 | 4.23 Billion CNY | -5.59% |
| 2020 Q4 | 3.75 Billion CNY | -11.4% |
| 2019 Q1 | 3.89 Billion CNY | 7.81% |
| 2019 FY | 3.37 Billion CNY | -6.56% |
| 2019 Q2 | 3.82 Billion CNY | -1.65% |
| 2019 Q3 | 3.22 Billion CNY | -15.63% |
| 2019 Q4 | 3.37 Billion CNY | 4.45% |
| 2018 Q3 | 3.55 Billion CNY | 0.07% |
| 2018 Q2 | 3.55 Billion CNY | 12.18% |
| 2018 Q1 | 3.16 Billion CNY | 1.05% |
| 2018 FY | 3.6 Billion CNY | 15.17% |
| 2018 Q4 | 3.6 Billion CNY | 1.53% |
| 2017 FY | 3.13 Billion CNY | 79.44% |
| 2017 Q2 | 2.35 Billion CNY | 5.15% |
| 2017 Q3 | 2.83 Billion CNY | 20.43% |
| 2017 Q1 | 2.24 Billion CNY | 28.3% |
| 2017 Q4 | 3.13 Billion CNY | 10.45% |
| 2016 Q3 | 1.75 Billion CNY | 151.45% |
| 2016 Q1 | 293.68 Million CNY | -54.85% |
| 2016 FY | 1.74 Billion CNY | 168.55% |
| 2016 Q4 | 1.74 Billion CNY | -0.3% |
| 2016 Q2 | 696.7 Million CNY | 137.22% |
| 2015 Q2 | 336.99 Million CNY | 8.2% |
| 2015 Q1 | 311.46 Million CNY | 137.92% |
| 2015 Q3 | 609.37 Million CNY | 80.83% |
| 2015 Q4 | 650.4 Million CNY | 6.73% |
| 2015 FY | 650.4 Million CNY | 396.84% |
| 2014 FY | 130.9 Million CNY | 336.36% |
| 2014 Q4 | 130.9 Million CNY | 930.78% |
| 2014 Q1 | - CNY | -100.0% |
| 2014 Q3 | 12.7 Million CNY | 370.37% |
| 2014 Q2 | 2.7 Million CNY | 0.0% |
| 2013 Q4 | 30 Million CNY | -40.0% |
| 2013 Q2 | 37.6 Million CNY | -29.06% |
| 2013 Q1 | 53 Million CNY | 5788.89% |
| 2013 FY | 30 Million CNY | 3233.33% |
| 2013 Q3 | 50 Million CNY | 32.98% |
| 2012 Q2 | 49.1 Million CNY | 0.0% |
| 2012 Q1 | 49.1 Million CNY | 81967.22% |
| 2012 Q3 | 10 Million CNY | -79.63% |
| 2012 FY | 900 Thousand CNY | 1404.29% |
| 2012 Q4 | 900 Thousand CNY | -91.0% |
| 2011 Q3 | 179.48 Thousand CNY | -99.27% |
| 2011 Q4 | 59.82 Thousand CNY | -66.67% |
| 2011 Q2 | 24.5 Million CNY | 63.33% |
| 2011 Q1 | 15 Million CNY | 0.0% |
| 2011 FY | 59.82 Thousand CNY | -99.6% |
| 2010 Q4 | 15 Million CNY | 0.0% |
| 2010 FY | 15 Million CNY | -51.61% |
| 2009 FY | 31 Million CNY | -25.03% |
| 2008 FY | 41.35 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | 3.34 Billion CNY | -28.24% |
| Dirui Industrial Co.,Ltd. | 714.1 Million CNY | -500.982% |
| Beijing Strong Biotechnologies, Inc. | 1.13 Billion CNY | -277.911% |
| Medicalsystem Biotechnology Co., Ltd. | 108.17 Million CNY | -3867.47% |
| Maccura Biotechnology Co.Ltd | 665.16 Million CNY | -545.204% |
| Guangzhou Wondfo Biotech Co.,Ltd | 599.53 Million CNY | -615.827% |
| Guangdong Hybribio Biotech Co.,Ltd. | 56.65 Million CNY | -7475.421% |
| BGI Genomics Co., Ltd. | 1.09 Billion CNY | -291.431% |
| Amoy Diagnostics Co., Ltd. | 108.34 Million CNY | -3861.062% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | 374.62 Million CNY | -1045.597% |